Company news
AnaptysBio, Inc. news in 2019
AnaptysBio, Inc.'s news releases, calls and decks from 2019, newest first.
AnaptysBio Reports Etokimab ATLAS Phase 2b Clinical Trial in Moderate-to-Severe Atopic Dermatitis Fails to Meet Primary Endpoint
November 7, 2019
AnaptysBio Announces Third Quarter 2019 Financial Results and Provides Pipeline Updates
November 7, 2019
AnaptysBio Reports Positive Topline Data from Interim Analysis of GALLOP Phase 2 Clinical Trial of ANB019 Monotherapy in Moderate-to-Severe Generalized Pustular Psoriasis
September 29, 2019
AnaptysBio to Present at the Cantor Fitzgerald Global Healthcare Conference
September 26, 2019